FDAAA Leadership
General Counsel
Erika Lietzan, Esq.
Erika Lietzan is a partner in the food and drug group of Covington & Burling LLP. She focuses on FDA regulation of prescription and OTC drugs, biologics, and medical devices, and she has also advised clients in the food, dietary supplement, and cosmetic industries. Her work includes advocacy at FDA, advisory work and strategic advice relating to FDA matters, and assistance with related legislative strategies on Capitol Hill and related legislative and litigation strategies in the states. She is an active member of the Food & Drug Law Institute, serving on the editorial advisory board for its Journal, and she was recently elected a member of the American Law Institute. Erika also chairs the American Bar Association's committee on Biotechnology Law, and she is a frequent speaker and writer on FDA issues.